Tucidinostat Plus R-CHOP Improves EFS in DLBCL Expressing MY

Tucidinostat plus R-CHOP improved efficacy and was safe in previously untreated DLBCL expressing MYC and BCL2.

Related Keywords

China , Shanghai , Weili Zhao , Shanghai Institute Of Hematology , Key Laboratory Of Medical Genomics , International Prognostic Index , National Research Center , Shanghai Institute , State Key Laboratory , Medical Genomics , Translational Medicine , Ruijin Hospital Affiliated , Shanghai Jiao Tong University School ,